Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Johnston F et al. – Circulating mesothelin is a useful biomarker for pancreatic disease. Furthermore, mesothelin–specific T cells can be induced in patients with pancreatic cancer. This suggests that mesothelin is a potential target for immune–based intervention strategies in pancreatic cancer.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address